Quantum-Si (NASDAQ:QSI – Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.11) EPS for the quarter, hitting the consensus estimate of ($0.11), FiscalAI reports. Quantum-Si had a negative net margin of 5,605.88% and a negative return on equity of 47.35%. The company had revenue of $0.34 million during the quarter, compared to the consensus estimate of $0.30 million.
Here are the key takeaways from Quantum-Si’s conference call:
- Proteus launch delayed from the end of 2026 to the second quarter of 2027 as Quantum-Si adds an integrated instrument design cycle to improve repeatability, manufacturing yields, and product readiness.
- Management remains confident in the underlying sequencing technology and expects the additional development time could support launch detection of 19 or 20 amino acids, up from the previously planned 18.
- The company cited substantial market potential, including more than $4 billion annually in non-human proteomics and opportunities such as AAV serotyping, pathogen surveillance, and agricultural research; it has qualified more than 250 institutions interested in Proteus.
- Quantum-Si announced a targeted workforce reduction of approximately 20%, expected to generate about $12 million in annual operating expense savings and extend its cash runway into the fourth quarter of 2028.
- Second-quarter revenue fell to $344,000 from $591,000 a year earlier, while first-half revenue declined to $602,000 from $1.4 million; the company reiterated full-year 2026 revenue guidance of approximately $1 million.
Quantum-Si Stock Performance
NASDAQ:QSI traded down $0.05 on Thursday, hitting $0.79. The stock had a trading volume of 4,302,974 shares, compared to its average volume of 4,738,003. The stock has a market cap of $172.03 million, a P/E ratio of -1.55 and a beta of 3.24. Quantum-Si has a 1 year low of $0.69 and a 1 year high of $3.10. The firm’s fifty day simple moving average is $0.88 and its two-hundred day simple moving average is $0.93.
Wall Street Analysts Forecast Growth
View Our Latest Stock Report on Quantum-Si
Hedge Funds Weigh In On Quantum-Si
Several institutional investors have recently modified their holdings of the business. Virtu Financial LLC purchased a new stake in shares of Quantum-Si during the fourth quarter valued at approximately $262,000. Invesco Ltd. boosted its position in Quantum-Si by 36.2% in the fourth quarter. Invesco Ltd. now owns 402,821 shares of the company’s stock worth $443,000 after purchasing an additional 107,093 shares during the last quarter. XTX Topco Ltd boosted its position in Quantum-Si by 206.9% in the fourth quarter. XTX Topco Ltd now owns 461,982 shares of the company’s stock worth $508,000 after purchasing an additional 311,450 shares during the last quarter. Quadrature Capital Ltd bought a new position in Quantum-Si in the 4th quarter valued at $305,000. Finally, Barclays PLC grew its stake in Quantum-Si by 21.8% in the 4th quarter. Barclays PLC now owns 269,415 shares of the company’s stock valued at $296,000 after purchasing an additional 48,205 shares during the period. 39.90% of the stock is owned by institutional investors.
About Quantum-Si
Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.
Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.
Read More
- Five stocks we like better than Quantum-Si
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.
